{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:57:02Z","timestamp":1761807422567},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3106,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/jto.0b013e318060107c","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T11:09:19Z","timestamp":1209899359000},"page":"520-525","source":"Crossref","is-referenced-by-count":7,"title":["A Phase II Trial of Carboplatin\/Vinorelbine with Pegfilgrastim Support for the Treatment of Patients with Advanced Non-small Cell Lung Cancer"],"prefix":"10.1016","volume":"2","author":[{"given":"Richard F.","family":"Riedel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Garst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Dunphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"James E.","family":"Herndon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e318060107c_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2006","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1097\/JTO.0b013e318060107c_bib2","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1200\/JCO.1996.14.10.2774","article-title":"Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small cell lung cancer","volume":"14","author":"Crawford","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JCO.1994.12.2.360","article-title":"Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients","volume":"12","author":"Le Chevalier","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","article-title":"Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]: a randomised controlled trial","volume":"7","author":"Douillard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib5","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1056\/NEJMoa043623","article-title":"Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer","volume":"352","author":"Winton","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e318060107c_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa031644","article-title":"Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer","volume":"350","author":"Arriagada","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e318060107c_bib7","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1200\/jco.2006.24.18_suppl.7011","article-title":"CISCA (cisplatin vs. carboplatin) meta-analysis: an individual patient data meta-analysis comparing cisplatin versus carboplatin-based chemotherapy in first-line treatment of advanced non-small cell lung cancer (Abstract)","volume":"24","author":"Ardizzoni","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-5002(03)00280-0","article-title":"Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial","volume":"43","author":"Paccagnella","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318060107c_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-5002(03)00140-5","article-title":"Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer","volume":"41","author":"Mazzanti","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318060107c_bib10","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/annonc\/mdf332","article-title":"Phase III randomized trial comparing paclitaxel\/carboplatin with paclitaxel\/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial","volume":"13","author":"Rosell","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib11","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1200\/JCO.2003.12.046","article-title":"Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group","volume":"21","author":"Fossella","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib12","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1200\/JCO.1990.8.9.1556","article-title":"A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861","volume":"8","author":"Klastersky","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0169-5002(00)00218-X","article-title":"Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer","volume":"32","author":"Horvath","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318060107c_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3816\/CLC.2005.n.026","article-title":"Multicenter phase II trial of carboplatin\/vinorelbine in elderly patients with advanced non-small-cell lung cancer efficacy and impact on quality of life: Groupe Francais de Pneumo-Cancerlogie Study 9902","volume":"7","author":"LeCaer","year":"2005","journal-title":"Clin Lung Cancer"},{"key":"10.1097\/JTO.0b013e318060107c_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.lungcan.2005.03.029","article-title":"Randomized study of vinorelbine-gemcitabine versus vinorelbine-carboplatin in patients with advanced non-small cell lung cancer","volume":"49","author":"Tan","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318060107c_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000067765","article-title":"Vinorelbine and carboplatin in inoperable non-small cell lung cancer: a monoinstitutional phase II study","volume":"64","author":"Cremonesi","year":"2003","journal-title":"Oncology"},{"key":"10.1097\/JTO.0b013e318060107c_bib17","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0169-5002(01)00387-7","article-title":"Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study","volume":"34","author":"Agelaki","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318060107c_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1634\/theoncologist.6-suppl_1-12","article-title":"Carboplatin and vinorelbine in advanced non-small cell lung cancer: a phase I\/II study","volume":"6","author":"Masters","year":"2001","journal-title":"Oncologist"},{"key":"10.1097\/JTO.0b013e318060107c_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00000421-199802000-00015","article-title":"Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer: a multicenter phase II study","volume":"21","author":"Santomaggio","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s002800050436","article-title":"Carboplatin and vinorelbine in advanced non-small-cell lung cancer","volume":"37","author":"Pronzato","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1097\/JTO.0b013e318060107c_bib21","first-page":"73","article-title":"Vinorelbine (Navelbine)\/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor","volume":"21","author":"Crawford","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/annonc\/mdg019","article-title":"A randomized double-blind multicenter phase III study of fixed-dose single administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy","volume":"14","author":"Green","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.20.3.727","article-title":"Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III\/IV breast cancer","volume":"20","author":"Holmes","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib24","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2000.18.13.2522","article-title":"Randomized dose-escalation study of SD\/01 compared with daily filgrastim in patients receiving chemotherapy","volume":"18","author":"Johnston","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib25","first-page":"552","article-title":"Hematopoietic growth factors in the reduction of chemotherapeutic toxicity","volume":"25","author":"Johnston","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(05)70255-2","article-title":"Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomized trials","volume":"6","author":"Di Maio","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib27","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1200\/JCO.2003.06.099","volume":"21","author":"Gridelli","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jnci\/91.1.66","article-title":"Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group","volume":"91","author":"The Elderly Lung Cancer Vinorelbine Italian Study Group","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e318060107c_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jnci\/95.5.362","article-title":"Chemotherapy for elderly patients with advanced non-small-cell lung cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial","volume":"95","author":"Gridelli","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e318060107c_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0140-6736(93)91350-U","article-title":"Granulocyte and granulocyte-macrophage colony-stimulating factors","volume":"342","author":"Steward","year":"1993","journal-title":"Lancet"},{"key":"10.1097\/JTO.0b013e318060107c_bib31","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1200\/JCO.2005.09.102","article-title":"First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study","volume":"23","author":"Vogel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib32","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/sj.bjc.6603085","article-title":"Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer","volume":"94","author":"Kummel","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e318060107c_bib33","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1200\/JCO.2005.02.8621","article-title":"Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every 2-week adjuvant breast cancer chemotherapy","volume":"23","author":"Burstein","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib34","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","volume":"21","author":"Citron","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/annonc\/mdg069","article-title":"Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluoruracil: a randomized phase III trial in locally advanced breast cancer","volume":"14","author":"Baldini","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib36","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1200\/JCO.2002.12.113","article-title":"Dose-dense anthracycline-based chemotherapy for node-positive breast cancer","volume":"20","author":"Ellis","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318060107c_bib37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","article-title":"Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial","volume":"7","author":"Douillard","year":"2006","journal-title":"Lancet Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415308054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415308054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T05:57:18Z","timestamp":1588658238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415308054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1556086415308054"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e318060107c","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}